Treatment of Early Unfavorable Classic Hodgkin Lymphoma

For information about the treatments listed below, see the Treatment Option Overview section.

Treatment of early unfavorable classic Hodgkin lymphoma in adults may include the following:

• Combination chemotherapy with radiation therapy to the areas of the body with cancer.
• Combination chemotherapy.
• Targeted therapy with a monoclonal antibody (brentuximab vedotin) and combination chemotherapy with or without radiation therapy.

Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.